Tamoxifen Initiation After Ductal Carcinoma In Situ.

The Oncologist
Hazel B NicholsDiana S M Buist

Abstract

Endocrine therapy initiation after ductal carcinoma in situ (DCIS) is highly variable and largely unexplained. National guidelines recommend considering tamoxifen for women with estrogen receptor-positive (ER+) DCIS or who undergo excision alone. We evaluated endocrine therapy use after DCIS over a 15-year period in an integrated health care setting to identify factors related to initiation. Female Group Health Cooperative enrollees ages 18-89 years with a DCIS diagnosis during 1996-2011 were eligible for inclusion. Endocrine therapy was identified through pharmacy records. Tumor and treatment information were from tumor registry reports; demographics and other risk factors were from questionnaires and electronic medical records. Relative risks (RRs) and 95% confidence intervals (CIs) for endocrine therapy initiation were calculated using multivariable generalized linear models. We identified 727 women with a DCIS diagnosis, including 163 (22%) who initiated endocrine therapy (149 tamoxifen, 14 aromatase inhibitor). Younger women were more likely to initiate endocrine therapy (RR 1.69; 95% CI 1.16-2.46 for ages 45-54 vs. 65-74 years). Compared with breast-conserving surgery (BCS) with radiation, women who had BCS alone (RR 0.46...Continue Reading

References

Nov 5, 1999·Journal of the National Cancer Institute·M H GailV Vogel
May 20, 2004·The Annals of Pharmacotherapy·Denise M BoudreauBarry G Saver
Jun 24, 2004·Journal of the American Geriatrics Society·Diana S M BuistThomas Abbott
Jul 1, 2005·American Journal of Epidemiology·Donna Spiegelman, Ellen Hertzmark
Nov 1, 2005·Journal of the American College of Surgeons·Faina NakhlisMonica Morrow
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tina W F YenJane C Weeks
Dec 22, 2007·American Journal of Surgery·Leron C JacksonJohn H Stewart
Feb 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marina Parton, Ian E Smith
Jan 27, 2009·Menopause : the Journal of the North American Menopause Society·Amanda I Phipps, Diana S M Buist
Feb 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Todd M TuttleBeth A Virnig
May 12, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary E RopkaJohn T Philbrick
Oct 20, 2010·Journal of the National Cancer Institute. Monographs·Karla Kerlikowske
Oct 20, 2010·Journal of the National Cancer Institute. Monographs·Jennifer Eng-WongSandra M Swain
May 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew N FreedmanWorta McCaskill-Stevens
Sep 10, 2011·Journal of Women's Health·Jennifer C LivaudaisCelia P Kaplan
Mar 7, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Craig AllredNorman Wolmark
Mar 7, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Monica Morrow
Oct 19, 2012·Journal of Oncology Practice·Erin J Aiello BowlesDenise M Boudreau
May 7, 2013·Journal of the National Cancer Institute·Djøra I SoetemanRinaa S Punglia
Aug 28, 2013·Breast Cancer Research and Treatment·Brian L SpragueAmy Trentham-Dietz
Sep 27, 2013·Journal of the National Cancer Institute·Rinaa S PungliaJane C Weeks
Jul 16, 2014·The Breast : Official Journal of the European Society of Mastology·H StaleyJ Bruce
Jan 28, 2015·SpringerPlus·Heather Spencer FeigelsonLaurel A Habel

❮ Previous
Next ❯

Citations

Aug 11, 2016·The Breast : Official Journal of the European Society of Mastology·Angela TossMassimo Cristofanilli
Apr 14, 2016·Journal of Oncology Practice·Monica Morrow
Oct 24, 2017·Journal of Cancer Epidemiology·Chelsea AndersonHazel B Nichols
Nov 3, 2016·Breast Cancer Research and Treatment·Chinwe C MadubataGraham A Colditz
Nov 8, 2017·Frontiers in Oncology·Kylie L Gorringe, Stephen B Fox
Jun 28, 2018·Breast Cancer Research and Treatment·Natasha K StoutRinaa S Punglia
Sep 13, 2017·Frontiers in Oncology·Yasuaki SagaraMasakazu Toi
Apr 1, 2017·Journal of the National Cancer Institute·Eileen RakovitchLawrence Paszat
Jun 13, 2019·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Marc D RyserE Shelley Hwang
Mar 26, 2021·Cancer Research·Christopher I LiKathleen E Malone
May 22, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Apar GuptaShi-Yi Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
hysterectomy

Software Mentioned

SAS

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

© 2022 Meta ULC. All rights reserved